Recent data have suggested a recurrent panel of cytokines, encompassing B-Lymphocyte stimulator (BlyS or BAFF), interleukin (IL)-37, IL-2, IL-10, IL-17A and IL-18, that are likely involved in LN onset and progression [4,6,7,8,9,10,11]. The gene discussed is TNFSF13B; the disease is lobular neoplasia.